Oxidative stress: potential of distinct peroxide determination systems

References

1 Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11:81–128.10.1016/0891-5849(91)90192-6Search in Google Scholar

2 Schaur RJ. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med 2003; 24:149–59.10.1016/S0098-2997(03)00009-8Search in Google Scholar

3 Siems W, Grune T. Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med 2003; 24:167–75.10.1016/S0098-2997(03)00011-6Search in Google Scholar

4 Zarkovic N. 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 2003; 24:281–91.10.1016/S0098-2997(03)00023-2Search in Google Scholar

5 Esterbauer H. Estimation of peroxidative damage. A critical review. Pathol Biol (Paris) 1996; 44:25–8.Search in Google Scholar

6 Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998; 44:1309–15.10.1093/clinchem/44.6.1309Search in Google Scholar

7 Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994; 234:279–93.10.1016/0076-6879(94)34095-1Search in Google Scholar

8 Jialal I, Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin Chem 1996; 42:498–506.10.1093/clinchem/42.4.498Search in Google Scholar

9 Lands LC, Grey VL, Grenier C. Total plasma antioxidant capacity in cystic fibrosis. Pediatr Pulmonol 2000; 29:81–7.10.1002/(SICI)1099-0496(200002)29:2<81::AID-PPUL1>3.0.CO;2-NSearch in Google Scholar

10 Lantos J, Roth E, Czopf L, Nemes J, Gal I. Monitoring of plasma total antioxidant status in different diseases. Acta Chir Hung 1997; 36:188–9.Search in Google Scholar

11 Child RB, Wilkinson DM, Fallowfield JL., Donnelly AE. Elevated serum antioxidant capacity and plasma malondialdehyde concentration in response to a simulated half-marathon run. Med Sci Sports Exerc 1998; 30:1603–7.10.1097/00005768-199811000-00008Search in Google Scholar

12 MacKinnon KL, Molnar Z, Lowe D, Watson ID, Shearer E. Measures of total free radical activity in critically ill patients. Clin Biochem 1999; 32:263–8.10.1016/S0009-9120(98)00109-XSearch in Google Scholar

13 Winkler R, Griebenow S, Wonisch W. Effect of iodide on total antioxidant status of human serum. Cell Biochem Funct 2000; 18:143–6.10.1002/(SICI)1099-0844(200006)18:2<143::AID-CBF857>3.0.CO;2-#Search in Google Scholar

14 Krstevska M, Dzhekova-Stojkova S, Bosilkova G. Menopause, coronary artery disease and antioxidants. Clin Chem Lab Med 2001; 39:641–4.10.1515/CCLM.2001.104Search in Google Scholar

15 Opara EC, Abdel-Rahman E, Soliman S, Kamel WA, Souka S, Lowe JE, et al. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism 1999; 48:1414–7.10.1016/S0026-0495(99)90152-XSearch in Google Scholar

16 Napoli C. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies. G Ital Cardiol 1997; 27:1302–14.Search in Google Scholar

17 Vaarala O. Antibodies to oxidised LDL. Lupus 2000; 9:202–5.10.1191/096120300678828280Search in Google Scholar

18 Inoue T, Uchida T, Kamishirado H, Takayanagi K, Hayashi T, Morooka S. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 2001; 37:775–9.10.1016/S0735-1097(00)01199-2Search in Google Scholar

19 Buonocore G, Perrone S, Longini M, Terzuoli L, Bracci R. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res 2000; 47:221–4.10.1203/00006450-200002000-00012Search in Google Scholar

20 Poli G, Schaur RJ. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. Life 2000; 50:315–21.Search in Google Scholar

21 Felley CP, Pignatelli B, Van Melle GD, Crabtree JE, Stolte M, Diezi J, et al. Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication. Helicobacter 2002; 7:342–8.10.1046/j.1523-5378.2002.00107.xSearch in Google Scholar

22 Bostan M, Brasoveanu LI, Livescu A, Manda G, Neagu M, Iordachescu D. Effects of synovial fluid on respiratory burst of granulocytes in rheumatoid arthritis. J Cell Mol Med 2001; 5:188–94.10.1111/j.1582-4934.2001.tb00152.xSearch in Google Scholar

23 Niess AM, Dickhuth HH, Northoff H, Fehrenbach E. Free radicals and oxidative stress in exercise – immunological aspects. Exerc Immunol Rev 1999; 5:22–56.Search in Google Scholar

24 Riserus U, Basu S, Jovinge S, Fredrikson GN, Arnlov J, Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 2002; 106:1925–9.10.1161/01.CIR.0000033589.15413.48Search in Google Scholar

25 Festa A, Kopp HP, Menzel EJ. Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 1998; 41:350–60.10.1007/s001250050914Search in Google Scholar

26 Cesarone MR, Belcaro G, Caratelli M, Cornelli U, De Sanctis MT, Incandela L, et al. A simple assay to monitor oxidative stress. Int Angiol 1999; 18:127–30.Search in Google Scholar

27 Elstner EF. Der Sauerstoff: Die biologische OH•-Bildung. Mannheim-Wien-Zürich: Wissenschaftsverlag, 1990.Search in Google Scholar

28 Minotti G, Aust SD. The role of iron in the initiation of lipid peroxidation. Chem Phys Lipids 1987; 44:191–208.10.1016/0009-3084(87)90050-8Search in Google Scholar

29 Parmigiani S, Gambini L, Massari A, Pezzani I, Payer C, Bevilacqua G. Evaluation of reactive oxygen metabolites with micromethod in neonates: determination of standards of normality in full-term babies. Acta Biomed Ateneo Parmense 1997; 68Suppl 1:103–6.Search in Google Scholar

30 Digiesi V, Oliviero C, Gianno V, Rossetti M, Fiorillo C, Oradei A, et al. Reactive metabolites of oxygen, lipid peroxidation, total antioxidant capacity and vitamin E in essential arterial hypertension. Clin Ter 1997; 148:515–9.Search in Google Scholar

31 Tatzber F, Griebenow S, Wonisch W, Winkler R. Dual method for the determination of peroxidase-activity and total peroxides – iodide leads to a significant increase of peroxidase activity in human sera. Anal Biochem 2003; 316:147–53.10.1016/S0003-2697(02)00652-8Search in Google Scholar

32 Schippinger G, Wonisch W, Abuja PM, Fankhauser F, Winklhofer-Roob BM, Halwachs G. Lipid peroxidation and antioxidant status in professional American football players during competition. Eur J Clin Invest 2002; 32:686–92.10.1046/j.1365-2362.2002.01021.xSearch in Google Scholar

33 Roob JM, Khoschsorur G, Tiran A, Horina JH, Holzer H, Winklhofer-Roob BM. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000; 11:539–49.10.1681/ASN.V113539Search in Google Scholar

34 Tatzber F, Esterbauer H. Autoantibodies to oxidized low density lipoprotein. In: Bellomo G, Finardi G, Maggi E, Rice-Evans C, editors. Free radicals IX. London: Richelieu Press, 1995:245–62.Search in Google Scholar

35 Thomas L, Abdelhamid S. Diagnostische Sensitivität und Spezifität. In: Thomas L, editor. Labor und Diagnose, 4th ed. Frankfurt: Medizinische Verlagsgesellschaft Marburg, 1995:1863–4.Search in Google Scholar

36 O’Connell MJ, Peters TJ. Ferritin and haemosiderin in free radical generation, lipid peroxidation and protein damage. Chem Phys Lipids 1987; 45:241–9.10.1016/0009-3084(87)90067-3Search in Google Scholar

37 Hostmark AT, Lystad E, Vellar OD, Hovi K, Berg JE. Reduced plasma fibrinogen, serum peroxides, lipids, and apolipoproteins after a 3-week vegetarian diet. Plant Foods Hum Nutr 1993; 43:55–61.10.1007/BF01088096Search in Google Scholar

38 McLemore JL, Beeley P, Thorton K, Morrisroe K, Blackwell W, Dasgupta A. Rapid automated determination of lipid hydroperoxide concentrations and total antioxidant status of serum samples from patients infected with HIV: elevated lipid hydroperoxide concentrations and depleted total antioxidant capacity of serum samples. Am J Clin Pathol 1998; 109:268–73.10.1093/ajcp/109.3.268Search in Google Scholar

39 Szymczyk G, Beltowski J, Marciniak A, Kotarski J. Assessment of serum lipid peroxide levels and antioxidant status in females who had undergone total abdominal hysterectomy without closing of the peritoneum. Ginekol Pol 2003; 74:1397–403.Search in Google Scholar

40 Agil A, Fuller CJ, Jialal I. Susceptibility of plasma to ferrous iron/hydrogen peroxide-mediated oxidation: demonstration of a possible Fenton reaction. Clin Chem 1995; 41:220–5.10.1093/clinchem/41.2.220Search in Google Scholar

41 Esterbauer H, Benedetti A, Lang J, Fulceri R, Fauler G, Comporti M. Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation. Biochim Biophys Acta 1986; 876:154–66.10.1016/0005-2760(86)90329-2Search in Google Scholar

42 Herrero A, Portero-Otin M, Bellmunt MJ, Pamplona R, Barja G. Effect of the degree of fatty acid unsaturation of rat heart mitochondria on their rates of H2O2 production and lipid and protein oxidative damage. Mech Ageing Dev 2001; 122:427–43.10.1016/S0047-6374(01)00214-7Search in Google Scholar

43 Gieseg S, Duggan S, Gebicki JM. Peroxidation of proteins before lipids in U937 cells exposed to peroxyl radicals. Biochem J 2000; 350:215–8.10.1042/bj3500215Search in Google Scholar

44 Garcia-Ruiz C, Colell A, Morales A, Kaplowitz N, Fernandez-Checa JC. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol 1995; 48:825–34.Search in Google Scholar

45 Wonisch W, Hayn M, Schaur RJ, Tatzber F, Kranner I, Grill D, et al. Increased stress parameter synthesis in the yeast Saccharomyces cerevisiae after treatment with 4-hydroxy-2-nonenal. FEBS Lett 1997; 405:11–5.10.1016/S0014-5793(97)00123-3Search in Google Scholar

46 Prior RL, Cao G. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 1999; 27:1173–81.10.1016/S0891-5849(99)00203-8Search in Google Scholar

47 Brown S, Georgatos M, Reifel C, Song JH, Shin SH, Hong M. Recycling processes of cellular ascorbate generate oxidative stress in pancreatic tissues in in vitro system. Endocrine 2002; 18:91–6.10.1385/ENDO:18:1:91Search in Google Scholar

48 Stocker R. The ambivalence of vitamin E in atherogenesis. Trends Biochem Sci 1999; 24:219–23.10.1016/S0968-0004(99)01404-8Search in Google Scholar

49 Bowen HT, Omaye ST. Oxidative changes associated with beta-carotene and alpha-tocopherol enrichment of human low-density lipoproteins. J Am Coll Nutr 1998; 17:171–9.10.1080/07315724.1998.10718743Search in Google Scholar

50 Stanger O, Semmelrock HJ, Wonisch W, Bös U, Pabst E, Wascher TC. Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther 2002; 303:158–62.10.1124/jpet.102.036715Search in Google Scholar

51 Wildburger R, Borovic S, Zarkovic N, Tatzber F. Post-traumatic dynamic changes in the antibody titer against oxidized low density lipoproteins. Wien Klin Wochenschr 2000; 112:798–803.Search in Google Scholar

52 Luc G, Fruchart JC. Oxidation of lipoproteins and atherosclerosis. Am J Clin Nutr 1991; 53(1 Suppl):206S–9S.10.1093/ajcn/53.1.206SSearch in Google Scholar

53 Inoue T, Inoue K, Maeda H, Takayanagi K, Morooka S. Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL concentrations in dyslipidemic patients. Clin Chim Acta 2001; 305:115–21.10.1016/S0009-8981(00)00426-5Search in Google Scholar

54 Pincemail J, Lecomte J, Castiau JP, Collard E, Vasankari T, Cheramy-Bien JP, et al. Evaluation of autoantibodies against oxidized LDL and antioxidant status in top soccer and basketball players after 4 months of competition. Free Radic Biol Med 2000; 28:559–65.10.1016/S0891-5849(99)00259-2Search in Google Scholar

55 Steinerova A, Stozicky F, Racek J, Tatzber F, Zima T, Stetina R. Antibodies against oxidized LDL in infants. Clin Chem 2001; 47:1137–8.10.1093/clinchem/47.6.1137Search in Google Scholar

56 Shoji T, Nishizawa Y, Fukumoto M, Shimamura K, Kimura J, Kanda H, et al. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 2000; 148:171–7.10.1016/S0021-9150(99)00218-XSearch in Google Scholar

57 Strohmaier W, Reiger J, Tatzber F, Wonisch W, Schlag G, Esterbauer H. Septicemic patients show a decrease in neopterin levels and an increase in autoantibodies to oxidized LDL (oLAb) after successful therapeutic intervention. Biofactors 1997; 6:279–80.Search in Google Scholar

58 Schumacher M, Eber B, Tatzber F, Kaufmann P, Halwachs G, Fruhwald FM, et al. Transient reduction of autoantibodies against oxidized LDL in patients with acute myocardial infarction. Free Radic Biol Med 1995; 18:1087–91.10.1016/0891-5849(94)00216-7Search in Google Scholar

59 Winklhofer-Roob BM, Van’t Hof MA, Shmerling DH. Reference values for plasma concentrations of vitamin E and A and carotenoids in a Swiss population from infancy to adulthood, adjusted for seasonal influences. Clin Chem 1997; 43:146–53.10.1093/clinchem/43.1.146Search in Google Scholar